Lung Cancer, Non-Small Cell : Related News

A Memorial Sloan-Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Memorial Sloan-Kettering now offers low-dose CT screening for certain smokers at high risk for lung cancer.

In our recently updated guides to non-small cell and small-cell lung cancers, you can learn about diagnosis, treatment, follow-up care, lung cancer experts, and clinical trials at Memorial Sloan-Kettering.

Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at diagnosis. The results enabled doctors to select the most appropriate drug designed to block the identified mutation and choose other treatment options for those patients whose tumors did not have a mutation.